HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pityriasis lichenoides in children: therapeutic response to erythromycin.

Abstract
Fifteen of twenty-two children with pityriasis lichenoides were treated with oral erythromycin. Eleven (73%) had a remission, usually within 2 months. Two others showed partial improvement, and two were unimproved. Seven of the children who experienced a remission were off erythromycin and free of lesions after 2 to 5 months of therapy. A trial of erythromycin as described herein should be considered in children with pityriasis lichenoides before other, possibly more toxic, measures are instituted.
AuthorsA P Truhan, A A Hebert, N B Esterly
JournalJournal of the American Academy of Dermatology (J Am Acad Dermatol) Vol. 15 Issue 1 Pg. 66-70 (Jul 1986) ISSN: 0190-9622 [Print] United States
PMID3722512 (Publication Type: Journal Article)
Chemical References
  • Erythromycin
Topics
  • Adolescent
  • Child
  • Child, Preschool
  • Erythromycin (therapeutic use)
  • Female
  • Humans
  • Male
  • Pityriasis (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: